StockMacro
Menu

Mobia Medical

$11.85 -10% in 6 monthsMarket cap $394.5M

MOBI on XNAS, Health Care, Mobia Medical, Inc., job postings

Measures activity, not value. Not investment advice.

Institutional holders rose 52% to 64 while shares are up 23% in one month.

  • GoodCash $160.7M against $7.3M debt gives $153.4M net cash

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.

Industry
Surgical & medical instruments & apparatus (Health Care)
Website
mobia.com
Listed
Nasdaq, US
Last results
5 Nov 2026
Next results
no estimate
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $15.6M, net loss $17.3M.
Quarter to 31 Mar 2025: revenue $5.7M, net income -$10.7MQuarter to 31 Mar 2025: revenue $5.7M, net income -$10.7MQuarter to 30 Jun 2025: revenue $6.7M, net income -$10.5MQuarter to 30 Jun 2025: revenue $6.7M, net income -$10.5MQuarter to 30 Sep 2025: revenue $9.0M, net income -$11.4MQuarter to 30 Sep 2025: revenue $9.0M, net income -$11.4MQuarter to 31 Mar 2026: revenue $12.1M, net income -$17.7MQuarter to 31 Mar 2026: revenue $12.1M, net income -$17.7MQuarter to 30 Jun 2026: revenue $13.5M, net income -$21.0MQuarter to 30 Jun 2026: revenue $13.5M, net income -$21.0MQuarter to 30 Sep 2026: revenue $15.6M, net income -$17.3MQuarter to 30 Sep 2026: revenue $15.6M, net income -$17.3M
31 Mar 2025RevenueNet incomeNet losstallest bar $21.0M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$15.6M-$17.3M
30 Jun 2026$13.5M-$21.0M
31 Mar 2026$12.1M-$17.7M
30 Sep 2025$9.0M-$11.4M
30 Jun 2025$6.7M-$10.5M
31 Mar 2025$5.7M-$10.7M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. – –
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). – –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. – -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $160.7M –
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $7.3M –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$153.4M (net cash) –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.05 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $4.74
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. – 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 2.5 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Mobia MedicalMOBI (this company) $394.5M––––
CerusCERS $373.6Mloss1.5–-2.9%
Shoulder InnovationsSI $421.6Mloss6.5+55%-51.7%
MiMedxMDXG $445.1Mloss1.5-23%-6.3%
AngioDynamicsANGO $454.6Mloss1.4+8.2%-10.1%
EmbectaEMBC $341.1M3.90.33-7.6%8.6%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

+$21K

bought $21K, sold $0

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+52%

64 13F filers vs 42

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

25%

8.3M shares held by 13F filers (30 Sep 2026) of 33.3M outstanding (30 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

2.9%

983K shares sold short (30 Oct 2026) of 33.3M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

5.8

983K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+16%

850K shares sold short in the report before, 983K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

73%

73% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 54%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$40K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

4

4 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

4 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $11.85 on 20 Nov 2026, +0.9% over 12 months (12-month range $8.09 to $14.63)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders bought a net $14.7M in the last 12 months (the 12 months before: $0).
Revenue per quarter. Revenue $15.6M in the latest quarter, +73% on a year earlier.
Capital spending per quarter. Capital spending $58K in the latest quarter, -75% on a year earlier.
Institutional holders (13F filers). 64 13F filers reported holding it in the latest 13F quarter, +52% on a year earlier.
Lobbying spend. Lobbying spend: $40K published in the last 12 months, +300% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
3 Aug 20268-K and other filingsDirector or officer change
15 Jul 20268-K and other filingsDirector or officer change
15 Jul 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 May 2026Sharp changeClustered insider buying: clustered insider buying (5 independent filers, 5 filing(s) in 30 days, value_usd total 11.0M)
4 May 20268-K and other filingsRegistered new securities for sale (S-1)
27 Apr 20268-K and other filingsRegistered new securities for sale (S-1)
17 Apr 20268-K and other filingsRegistered new securities for sale (S-1)
18 Jul 2025Lobbying filingnew lobbying registration (JEFFREY J. KIMBELL & ASSOCIATES, INC.)
18 Jul 2025Sharp changeFirst lobbying registration: first lobbying registration: MOBIA MEDICAL, INC (FKA MICROTRANSPONDER): new lobbying registration (JEFFREY J. KIMBELL & ASSOCIATES, INC.)
14 Mar 20258-K and other filingsPrivate placement of securities (Form D)
21 Jun 20228-K and other filingsPrivate placement of securities (Form D)
Insider net buying (open market)
Month from 1 May 2026: $11.0M published
Month from 1 Jun 2026: $2.7M published
Month from 1 Aug 2026: $996K published
Month from 1 Sep 2026: $21K published
Revenue per quarter
Quarter ended 31 Mar 2025: $5.7M; public on 5 Jun 2026
Quarter ended 30 Jun 2025: $6.7M; public on 12 Aug 2026
Quarter ended 30 Sep 2025: $9.0M; public on 6 Nov 2026
Quarter ended 31 Mar 2026: $12.1M, +113% on a year earlier; public on 5 Jun 2026
Quarter ended 30 Jun 2026: $13.5M, +102% on a year earlier; public on 12 Aug 2026
Quarter ended 30 Sep 2026: $15.6M, +73% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Mar 2025: $23K; public on 5 Jun 2026
Quarter ended 30 Jun 2025: $0; public on 12 Aug 2026
Quarter ended 30 Sep 2025: $236K; public on 6 Nov 2026
Quarter ended 31 Mar 2026: $42K, +83% on a year earlier; public on 5 Jun 2026
Quarter ended 30 Sep 2026: $58K, -75% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
30 Jun 2026 report: 42; public on 14 Aug 2026
30 Sep 2026 report: 64; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Oct 2025: $10K published
Quarter from 1 Jan 2026: $10K published
Quarter from 1 Apr 2026: $10K published
Quarter from 1 Jul 2026: $10K published
Quarter from 1 Oct 2026: $10K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is 13F holders (funds reporting the stock) at 64 (30 Sep 2026), 1.5× its normal reading.
  • Insider net buying (open market): Insiders bought a net $14.7M in the last 12 months (the 12 months before: $0).
  • Revenue per quarter: Revenue $15.6M in the latest quarter, +73% on a year earlier.
  • Capital spending per quarter: Capital spending $58K in the latest quarter, -75% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 14 insider trades

Last 90 days: no sales; 1 purchase, $21K. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
15 Sep 2026Chase C. LeavittSEE REMARKSBuy2,000$10.30$21KForm 4
20 Aug 2026Casey M TanseyDirectorBuy16,441$12.07$198KForm 4
17 Aug 2026Casey M TanseyDirectorBuy68,559$11.63$797KForm 4
29 Jun 2026Green Park & Golf Ventures II, LLC and 5 others10% ownerBuy81,000$15.00$1.2MForm 4
29 Jun 2026GPG SC, LLC and 9 others10% ownerBuy33,333$15.00$500KForm 4
29 Jun 2026Carl D Soderstrom and 7 others10% ownerBuy60,537$15.00$908KForm 4
29 Jun 2026Gilbert G. Garcia II and 9 others10% ownerSell6,731Not filedNot filedForm 4
11 Jun 2026Nelson Bunker CurnesChief Financial OfficerBuy5,000$12.79$64KForm 4

64 institutions reported shares at the end of Q3 2026, 25% of the shares outstanding; 27 opened a position, 7 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Sr One Capital Management, LP2.0M5.96%$18.8MNo change
Aberdeen Group plc894K2.68%$8.5M+310K+53%
BlackRock, Inc.592K1.78%$5.6M+439K+287%
Point72 Asset Management, L.P.529K1.59%$5.0MNew+529K
Vanguard Capital Management LLC444K1.33%$4.2MNo change
Farallon Capital Management, L.L.C.438K1.31%$4.1M-691K-61%
Rock Springs Capital Management LP418K1.25%$4.0MNo change
Perceptive Advisors LLC344K1.03%$3.2M-180K-34%
Avidity Partners Management LP325K0.97%$3.1M-474K-59%
Balyasny Asset Management L.P.286K0.86%$2.7M-101K-26%

Company events

All 11 company events

In 12 months: 3 share registrations, 2 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
3 Aug 2026Director or officer change8-K
15 Jul 2026Director or officer change8-K
4 May 2026Registered new securities for sale (S-1)S-1/A
27 Apr 2026Registered new securities for sale (S-1)S-1/A
17 Apr 2026Registered new securities for sale (S-1)S-1
14 Mar 2025Private placement of securities (Form D)$32.5M sold of $65.0M offeredD
21 Jun 2022Private placement of securities (Form D)$32.9M sold of $52.9M offeredD
30 Jul 2021Private placement of securities (Form D)$6.0M sold of $6.0M offeredD

Reported lobbying spend: $10K in Q3 2026, $10K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
23 Jun 2025NewJeffrey J. Kimbell & Associates, Inc.for Mobia Medical, Inc (Fka Microtransponder)Issues related to medical devicesHealth issuesFiling

The 5 newest of 41 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 16 Sep 2026Insiders record

    Leavitt Chase C. (SEE REMARKS) bought 2,000 shares of MOBI ($20,600) (dated 15 Sep 2026)

  2. 21 Aug 2026Insiders record

    Tansey Casey M (director) bought 16,441 shares of MOBI ($198,443) (dated 20 Aug 2026)

  3. 18 Aug 2026Insiders record

    Tansey Casey M (director) bought 68,559 shares of MOBI ($797,253) (dated 17 Aug 2026)

  4. 3 Aug 2026Filings record

    Director or officer change

  5. 15 Jul 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 15 Jul 2026Filings record

    Director or officer change

  7. 30 Jun 2026Insiders record

    Green Park & Golf Ventures II, LLC (ten percent owner) and 5 other(s) bought 81,000 shares of MOBI ($1.2M) (dated 29 Jun 2026)

  8. 30 Jun 2026Insiders record

    GPG SC, LLC (ten percent owner) and 9 other(s) bought 33,333 shares of MOBI ($499,995) (dated 29 Jun 2026)

  9. 30 Jun 2026Insiders record

    Soderstrom Carl D (ten percent owner) and 7 other(s) bought 60,537 shares of MOBI ($908,055) (dated 29 Jun 2026)

  10. 12 Jun 2026Insiders record

    Curnes Nelson Bunker (Chief Financial Officer) bought 5,000 shares of MOBI ($63,950) (dated 11 Jun 2026)

  11. 13 May 2026Insiders record

    Osage University GP III, LLC (ten percent owner) and 3 other(s) bought 533,333 shares of MOBI [same transaction as an earlier filing] (dated 12 May 2026)

  12. 12 May 2026Insiders change

    had 5 insiders buy $11.0M of its shares on the open market within 30 days (5 filings).

    Who bought: Mead Dana G Jr., Tansey Casey M, Leavitt Chase C., Harrington William T and 1 more.

    See the evidence (5 source records)
    Independent buyers
    5
    Purchase filings (Form 4, code P)
    5
    Total bought
    $11.0M
    Window
    12 Apr 2026 to 12 May 2026
    • Mead Dana G Jr. (director) bought 7,000 shares of MOBI ($105,000)dated 11 May 2026, public 12 May 2026
    • Tansey Casey M (director) bought 66,666 shares of MOBI ($999,990)dated 11 May 2026, public 12 May 2026
    • Leavitt Chase C. (See Remarks) bought 3,000 shares of MOBI ($45,000)dated 11 May 2026, public 12 May 2026
    • HARRINGTON WILLIAM T (director) bought 533,333 shares of MOBI ($8.0M)dated 11 May 2026, public 12 May 2026
    • Lucchese Cynthia L (director) bought 125,000 shares of MOBI ($1.9M)dated 11 May 2026, public 12 May 2026

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  13. 12 May 2026Insiders record

    Mead Dana G Jr. (director) bought 7,000 shares of MOBI ($105,000) (dated 11 May 2026)

  14. 12 May 2026Insiders record

    Tansey Casey M (director) bought 66,666 shares of MOBI ($999,990) (dated 11 May 2026)

  15. 12 May 2026Insiders record

    Leavitt Chase C. (See Remarks) bought 3,000 shares of MOBI ($45,000) (dated 11 May 2026)

  16. 12 May 2026Insiders record

    HARRINGTON WILLIAM T (director) bought 533,333 shares of MOBI ($8.0M) (dated 11 May 2026)

  17. 12 May 2026Insiders record

    Lucchese Cynthia L (director) bought 125,000 shares of MOBI ($1.9M) (dated 11 May 2026)

  18. 4 May 2026Filings record

    Registered new securities for sale (S-1)

  19. 27 Apr 2026Filings record

    Registered new securities for sale (S-1)

  20. 17 Apr 2026Filings record

    Registered new securities for sale (S-1)

  21. 18 Jul 2025Lobbying change

    registered for federal lobbying for the first time in our data (Jeffrey J. Kimbell & Associates, Inc.).

    See the evidence (1 source record)
    Source coverage starts
    17 Jul 2008
    Earlier events of other kinds
    0

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

  22. 18 Jul 2025Lobbying record

    MOBIA MEDICAL, INC (FKA MICROTRANSPONDER): new lobbying registration (JEFFREY J. KIMBELL & ASSOCIATES, INC.) (dated 23 Jun 2025)

  23. 14 Mar 2025Filings record

    Private placement of securities (Form D)

  24. 21 Jun 2022Filings record

    Private placement of securities (Form D)

  25. 30 Jul 2021Filings record

    Private placement of securities (Form D)

  26. 8 Sep 2020Filings record

    Private placement of securities (Form D)

  27. 21 Nov 2017Filings record

    Private placement of securities (Form D)

  28. 7 Jul 2017Filings record

    Private placement of securities (Form D)

Not listed: 6 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001489993
Ticker
MOBI
Domain
mobia.com
Hq location
TX|AUSTIN|78738 (1 unverified)
Lobbying client
mobia medical inc fka microtransponder
Name
MicroTransponder, Inc., Mobia Medical, Inc.
  • Federal lobbying disclosures (LDA)1 record, 17 data points23 Jun 2025 to 30 Sep 2026
  • SEC Form 13F institutional holdings18 data points30 Jun 2026 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)16 records7 Jul 2017 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)84 data points31 Dec 2024 to 30 Oct 2026
  • SEC Form 4 insider transactions14 records, 28 data points11 May 2026 to 15 Sep 2026
  • FINRA short interest (twice monthly)35 data points15 May 2026 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)274 data points8 May 2026 to 20 Nov 2026